Search Results - "LABARGA, Pablo"

Refine Results
  1. 1

    Update on HIV/HCV Coinfection by Soriano, Vincent, Vispo, Eugenia, Fernandez-Montero, Jose Vicente, Labarga, Pablo, Barreiro, Pablo

    Published in Current HIV/AIDS reports (01-09-2013)
    “…Liver disease is currently one of the leading causes of hospitalization and death in HIV-positive individuals. Coinfection with the hepatitis C virus (HCV) is…”
    Get full text
    Journal Article
  2. 2

    Prevention and management of treatment failure to new oral hepatitis C drugs by Benítez-Gutiérrez, Laura, Barreiro, Pablo, Labarga, Pablo, de Mendoza, Carmen, Fernandez-Montero, José V, Arias, Ana, Peña, José M, Soriano, Vicente

    Published in Expert opinion on pharmacotherapy (12-06-2016)
    “…Chronic hepatitis C virus (HCV) infection has become a curable disease. Sustained virologic response rates above 90% have been achieved with recommended…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins by Sarobe, Pablo, Lasarte, Juan José, Casares, Noelia, López-Díaz de Cerio, Ascensión, Baixeras, Elena, Labarga, Pablo, García, Nicolás, Borrás-Cuesta, Francisco, Prieto, Jesús

    Published in Journal of Virology (01-05-2002)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  5. 5

    Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C by Soriano, Vincent, Vispo, Eugenia, de Mendoza, Carmen, Labarga, Pablo, Plaza, Zulema, Fernandez-Montero, Jose V, Poveda, Eva, Treviño, Ana, Barreiro, Pablo

    Published in Antiviral therapy (01-01-2013)
    “…Serum HCV RNA rebound beyond 24 weeks after completing hepatitis C therapy has been rarely reported. From 744 patients treated for chronic hepatitis C at our…”
    Get more information
    Journal Article
  6. 6

    Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era by Soriano, Vincent, MD, PhD, Labarga, Pablo, MD, PhD, Vispo, Eugenia, MD, Fernández-Montero, José Vicente, MD, PhD, Barreiro, Pablo, MD, PhD

    “…Chronic hepatitis C is a leading cause of clinical complications and mortality in individuals infected with human immunodeficiency virus (HIV). Approval for…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    New update of the DHHS guidelines for adults and children by Labarga, Pablo

    Published in AIDS reviews (01-04-2015)
    “…On April 2015, the U.S. Department of Health and Human Services (DHHS) released an updated version of its antiretroviral treatment guidelines for adults. The…”
    Get full text
    Journal Article
  10. 10

    HIV Protease Inhibitors Associated with Increased HCV Viral Load in Coinfected Patients by Labarga, Pablo

    Published in AIDS reviews (01-07-2015)
    “…Increases in serum HCV-RNA of 1 log on average after initiation of antiretroviral therapy have been reported in HIV/HCV-coinfected patients (Chung, et al…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    News on Antiretroviral Therapy by Labarga, Pablo

    Published in AIDS reviews (01-09-2014)
    “…The 2014 International Antiviral Society (IAS) Conference was held in Melbourne, Australia in July. This major HIV/AIDS scientific event was accompanied by the…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cancer in HIV patients by Labarga, Pablo

    Published in AIDS reviews (01-10-2013)
    “…Starting antiretroviral therapy (ART) with low CD4 counts raises the likelihood of certain cancers, but others increase with longer time on therapy, reflecting…”
    Get full text
    Journal Article
  17. 17

    Viral hepatitis and HIV co-infection by Soriano, Vincent, Vispo, Eugenia, Labarga, Pablo, Medrano, Jose, Barreiro, Pablo

    Published in Antiviral research (2010)
    “…Chronic hepatitis B virus (HBV) infection is overall recognised in 10% of HIV+ persons worldwide, with large differences according to geographical region…”
    Get full text
    Journal Article
  18. 18

    New promises for hepatitis C cure in HIV coinfection by Labarga, Pablo

    Published in AIDS reviews (01-01-2014)
    “…One of the most eagerly awaited news of 2013 was the approval in December of another two direct-acting antivirals for hepatitis C, Janssen's HCV protease…”
    Get full text
    Journal Article
  19. 19

    Bone mineral density loss, osteoporosis, and fractures in HIV by Labarga, Pablo

    Published in AIDS reviews (01-07-2013)
    “…The link between HIV and reduced bone mineral density, including osteopenia and the more severe osteoporosis, is well established. HIV infection has also been…”
    Get full text
    Journal Article
  20. 20

    Earlier Antiretroviral Therapy in HIV - As Soon As Possible by Labarga, Pablo

    Published in AIDS reviews (01-01-2013)
    “…Two recent reports in The New England Journal of Medicine have concluded that the best way to preserve the immune system, as assessed by measuring CD4+…”
    Get full text
    Journal Article